跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMLODIPINE SANDOZ TABLETS 5MG - HSA Drug Approval Details
Approvals
/
HSA
/
AMLODIPINE SANDOZ TABLETS 5MG
Approved
THERAPEUTIC
AMLODIPINE SANDOZ TABLETS 5MG
NOVARTIS PHARMACEUTICAL MANUFACTURING LLC - SLOVENIASANDOZ GRUP SAGLIK ÜRÜNLERI ILACLARI SAN. VE TIC. A.S. (GEBZE 2) (TURKEY)
🇸🇬 Health Sciences Authority
Approval Date
Mar 17, 2015
Approval ID
05cb3ff63f568619
Company
NOVARTIS PHARMACEUTICAL MANUFACTURING LLC - SLOVENIASANDOZ GRUP SAGLIK ÜRÜNLERI ILACLARI SAN. VE TIC. A.S. (GEBZE 2) (TURKEY)
Type
Therapeutic
Approval Details
Approval Id
05cb3ff63f568619
Drug Name
AMLODIPINE SANDOZ TABLETS 5MG
Product Name
AMLODIPINE SANDOZ TABLETS 5MG
Approval Number
SIN14756P
Approval Date
2015-03-17
Registrant
SANDOZ SINGAPORE PTE. LTD.
Licence Holder
SANDOZ SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C08CA01
Atc Item Name
amlodipine
Pharma Manufacturer Name
SANDOZ SINGAPORE PTE. LTD.
Company Detail Path
/organization/sandoz-singapore-pte-ltd
Active Ingredients
Amlodipine besilate 6.936mg eqv Amlodipine
5mg
AMLODIPINE BESILATE 6.936 MG EQV AMLODIPINE
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 17, 2015
Approval ID
05cb3ff63f568619
Type
Therapeutic
Back to HSA Approvals